Spit? Maybe..but Wait a Bit
Today, 23andMe, a Mountain View, California company, announced it will be collecting DNA samples from MPN patients to establish a large scale genomic database.
The stated aim in creating this large genotyped MPN cohort is to facilitate research into causes and cures of MPNs.
Participants in the project will be asked to provide a DNA sample and complete survey information on personal characteristics, disease states, and other as yet unspecified areas.
Beyond the opportunity to contribute to this large scale research resource, participants will receive a personal genomic report supposedly ranking their relative risk of acquiring various diseases. They will also have access to historical data tracing their family origins through their DNA.
MPNforum has interviewed scientists and consultants both within and outside 23andMe and researched the risks and rewards of participating in the program.
Our review and analysis with be published August 15, at http://www.mpnforum.com.